- Home
- VITL vs IRON Comparison
VITL vs IRON Comparison
Compare VITL & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VITL
- IRON
- Stock Information
- Founded
- VITL 2007
- IRON 2017
- Country
- VITL United States
- IRON United States
- Employees
- VITL N/A
- IRON N/A
- Industry
- VITL Packaged Foods
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- VITL Consumer Staples
- IRON Health Care
- Exchange
- VITL Nasdaq
- IRON Nasdaq
- Market Cap
- VITL 1.5B
- IRON 1.4B
- IPO Year
- VITL 2020
- IRON N/A
- Fundamental
- Price
- VITL $31.91
- IRON $46.68
- Analyst Decision
- VITL Strong Buy
- IRON Strong Buy
- Analyst Count
- VITL 8
- IRON 9
- Target Price
- VITL $43.88
- IRON $93.89
- AVG Volume (30 Days)
- VITL 809.4K
- IRON 354.8K
- Earning Date
- VITL 05-08-2025
- IRON 05-07-2025
- Dividend Yield
- VITL N/A
- IRON N/A
- EPS Growth
- VITL 30.46
- IRON N/A
- EPS
- VITL 1.13
- IRON N/A
- Revenue
- VITL $620,567,000.00
- IRON N/A
- Revenue This Year
- VITL $25.26
- IRON N/A
- Revenue Next Year
- VITL $19.41
- IRON N/A
- P/E Ratio
- VITL $28.29
- IRON N/A
- Revenue Growth
- VITL 23.96
- IRON N/A
- 52 Week Low
- VITL $27.91
- IRON $30.82
- 52 Week High
- VITL $48.41
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- VITL 41.85
- IRON 49.90
- Support Level
- VITL $31.40
- IRON $44.85
- Resistance Level
- VITL $36.28
- IRON $47.36
- Average True Range (ATR)
- VITL 1.16
- IRON 2.23
- MACD
- VITL -0.38
- IRON -0.12
- Stochastic Oscillator
- VITL 17.42
- IRON 37.58
About VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.